ATAC-seq of synovial sarcoma cell lines treated with the BRD9 PROTAC degrader WA-68
ChIP-seq / ATAC-seq (genome binding and open chromatin) · human · 17 samples
- What it is
- ChIP-seq / ATAC-seq (genome binding and open chromatin)Where proteins bind the genome, or which regions are open and active.
- Organism
- Homo sapiens (human)
- Topic
- Soft tissue sarcomaThis series is part of our curated briefing on it.
- Samples
- 17 samples: 8 conditions, mostly in duplicateGroups are read from the sample names, not from the paper. Check the list below.
- Data you can get
- A processed table (series matrix) and supplementary files from NCBI; the raw sequencing reads from ENA. Which of these hold counts depends on the study, so check the file list.
Read the full summary ↓
Direct links to NCBI and ENA, no account and no request form. Pick by what you want to do: take the small processed table to look, the supplementary files to re-analyse, or the original raw data to start over.
Processed table
The series matrix: one table of values per sample as the submitters processed it. The smallest download, and it opens in Excel or R. Start here to see what the data look like.
Supplementary files
The count tables and other files the authors uploaded. Take only the samples you need, or the whole study as GSE328410_RAW.tar (it can run to tens of gigabytes).
Raw sequencing reads
The original FASTQ files, straight from the sequencer, held at ENA. Large, and you align them yourself, so only choose this if you need to re-process the study from scratch.
What the files usually look like: Look for peak files (.bed, .narrowPeak) and signal tracks (.bigWig) among the supplementary files; the raw reads are on ENA.
Also filed as BioProject PRJNA1454924 and SRA study SRP692792. Searching any of these in the dataset finder brings you back here.
Supports a between-group comparison across 17 samples.
How we read this: 8 replicated groups read from 17 sample titles; they account for 17 of them. These groups are guessed from the sample names, not taken from the paper, so check them against the sample list below before relying on them.
- GSM9682383 SYO-1 ATAC-seq, DMSO, biol rep 1 SYO-1 ATAC-seq, DMSO, b…
- GSM9682384 SYO-1 ATAC-seq, DMSO, biol rep 2 SYO-1 ATAC-seq, DMSO, b…
- GSM9682385 SYO-1 ATAC-seq, WA-68 (100 nM), biol rep 1 SYO-1 ATAC-seq, WA-68 (…
- GSM9682386 SYO-1 ATAC-seq, WA-68 (100 nM), biol rep 2 SYO-1 ATAC-seq, WA-68 (…
- GSM9682387 HS-SY-II ATAC-seq, DMSO, biol rep 1 HS-SY-II ATAC-seq, DMSO…
- GSM9682388 HS-SY-II ATAC-seq, DMSO, biol rep 2 HS-SY-II ATAC-seq, DMSO…
- GSM9682389 HS-SY-II ATAC-seq, DMSO, biol rep 3 HS-SY-II ATAC-seq, DMSO…
- GSM9682390 HS-SY-II ATAC-seq, WA-68 (100 nM), biol rep 1 HS-SY-II ATAC-seq, WA-6…
- GSM9682391 HS-SY-II ATAC-seq, WA-68 (100 nM), biol rep 2 HS-SY-II ATAC-seq, WA-6…
- GSM9682392 HS-SY-II ATAC-seq, WA-68 (100 nM), 12 h, biol rep 1 HS-SY-II ATAC-seq, WA-6…
- GSM9682393 HS-SY-II ATAC-seq, WA-68 (100 nM), 12 h, biol rep 2 HS-SY-II ATAC-seq, WA-6…
- GSM9682394 HS-SY-II ATAC-seq, WA-68 (100 nM), 24 h, biol rep 1 HS-SY-II ATAC-seq, WA-6…
- GSM9682395 HS-SY-II ATAC-seq, WA-68 (100 nM), 24 h, biol rep 2 HS-SY-II ATAC-seq, WA-6…
- GSM9682396 HS-SY-II ATAC-seq, WA-68 (100 nM), 48 h, biol rep 1 HS-SY-II ATAC-seq, WA-6…
- GSM9682397 HS-SY-II ATAC-seq, WA-68 (100 nM), 48 h, biol rep 2 HS-SY-II ATAC-seq, WA-6…
- GSM9682398 HS-SY-II ATAC-seq, WA-68 (100 nM), 96 h, biol rep 1 HS-SY-II ATAC-seq, WA-6…
- GSM9682399 HS-SY-II ATAC-seq, WA-68 (100 nM), 96 h, biol rep 2 HS-SY-II ATAC-seq, WA-6…
- GSE224170 Chromatin status of rhabdomyosarcoma (RMS) cell line RH30 in repsonse to MyoD CRISPR/Cas9 deletion [RMS ATAC-seq] 6 samples same disease briefing · shares atac-seq, sarcoma
- GSE303149 CDK8 Inhibition Releases the Muscle Differentiation Blockade in Fusion-driven Alveolar Rhabdomyosarcoma [ATAC-seq] 6 samples same disease briefing · shares atac-seq, sarcoma
- GSE332748 PAX3::FOXO1-Targeting PROTAC Induces Myogenic Differentiation of Fusion-Positive Rhabdomyosarcoma Cells 6 samples same disease briefing · shares protac, sarcoma
- GSE144190 Systematic profiling of synovial sarcoma transcriptome 20 samples same disease briefing · shares synovial, sarcoma
- GSE131309 Opposing genetic and immune mechanisms shape oncogenic programs in synovial sarcoma 4 samples same disease briefing · shares synovial, sarcoma
- GSE303151 CDK8 Inhibition Releases the Muscle Differentiation Blockade in Fusion-driven Alveolar Rhabdomyosarcoma [CUT&RUN] 50 samples same disease briefing · shares sarcoma
- GSE292876 FANCM is Required for the PAX3::FOXO1-Driven Oncogenic Program in Rhabdomyosarcoma [ChIP-Seq] 18 samples same disease briefing · shares sarcoma
- GSE275736 A multitargeting approach rewires cell identity in fusion-negative rhabdomyosarcoma [bulk_ATACseq] 8 samples same disease briefing · shares sarcoma
Metadata from NCBI GEO, cached and refreshed periodically — the NCBI page above is authoritative. Downloads link straight to NCBI/ENA; nothing is proxied through BioTransfer.